Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

By sjmartinez • August 13, 2024

Narkhede M, Tomassetti S, Iqbal M, Tin A, Rivero-Hinojosa S, George GV, Widden H, Benrud R, Malhotra M, Rodriguez A, Liu MC. Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma. Front Oncol. 2024 Jul 29;14:1407003. doi: 10.3389/fonc.2024.1407003. PMID: 39135998; PMCID: PMC11317400.

Tags: circulating tumor DNA, Harbor UCLA, Hematology/Oncology, molecular residual disease, Next generation sequencing, Publications, surveillance, treatment response monitoring

Calcified aneurysm in the left anterior descending artery

Bishay R, Krishnan S, Budoff MJ. Calcified aneurysm in the left anterior descending artery. Coron Artery Dis. 2024 Oct 15. doi: 10.1097/MCA.0000000000001436. Epub ahead of[...]

Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial

Chew KW, McGinley B, Moser C, Li JZ, Evering TH, Ritz J, Javan AC, Margolis D, Wohl DA, Hughes MD, Daar ES, Currier JS, Eron[...]

Prevalence and Outcomes of Chronic Kidney Disease Associated Pruritus: International Results from PDOPPS

Tennankore KK, McCullough KP, Bieber B, Cho Y, Johnson DW, Kanjanabuch T, Kawanishi H, Kim YL, Lambie M, Rigatto C, Shen J, Schreiber M, Perl[...]